Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
Recruiting · NCT07624487 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, lung adenocarcinoma, lung neoplasm, neoplasm, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-06-18 | NCT07624487 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Taipei Medical University | 50 |
| Taipei Medical University Hospital | 12 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shuang Ho Hospital | New Taipei City | Taiwan | 5 |
| Taipei Medical University Hospital | Taipei | Taiwan | 19 |
| Wanfang Hospital | Taipei | Taiwan | 3 |